GET THE APP

Food Additives and Emulsifiers as Triggers of Mucosal Inflammation in IBD: A Review of Emerging Evidence+
Journal of Inflammatory Bowel Diseases & Disorders

Journal of Inflammatory Bowel Diseases & Disorders

ISSN: 2476-1958

Open Access

Commentary - (2025) Volume 10, Issue 2

Food Additives and Emulsifiers as Triggers of Mucosal Inflammation in IBD: A Review of Emerging Evidence+

Havila Ansona*
*Correspondence: Havila Ansona, Department of Obstetrics and Gynecology, University of Gothenburg, Gothenburg, Sweden, Email:
Department of Obstetrics and Gynecology, University of Gothenburg, Gothenburg, Sweden

Received: 01-May-2025, Manuscript No. jibdd-25-165634; Editor assigned: 03-May-2025, Pre QC No. P-165634; Reviewed: 17-May-2025, QC No. Q-165634; Revised: 22-May-2025, Manuscript No. R-165634; Published: 29-May-2025 , DOI: 10.37421/2476-1958.2025.10.248
Citation: Ansona, Havila. “Food Additives and Emulsifiers as Triggers of Mucosal Inflammation in IBD: A Review of Emerging Evidence.” J Inflamm Bowel Dis 10 (2025): 248.
Copyright: © 2025 Ansona H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Inflammatory Bowel Disease (IBD), which includes Crohnâ??s disease and ulcerative colitis, is a chronic, relapsing condition marked by inflammation of the gastrointestinal tract. The exact etiology of IBD is multifactorial, involving a combination of genetic, immune, and environmental factors. Over the past few decades, there has been increasing recognition of the role diet plays in the pathogenesis and exacerbation of IBD. In particular, food additives and emulsifiers, commonly used in processed foods to enhance texture, shelf life, and flavor, have come under scrutiny as potential contributors to mucosal inflammation in IBD. While traditionally seen as benign, emerging evidence suggests that these substances may disrupt gut microbiota, alter intestinal permeability, and trigger immune responses that exacerbate IBD pathology [1].

Description

Food additives encompass a wide variety of substances used to preserve, flavor, or color food. Emulsifiers, a subset of food additives, are particularly prevalent in processed foods, where they help blend ingredients that would otherwise separate, such as oil and water. Common emulsifiers like Carboxymethylcellulose (CMC) and Polysorbate 80 (P80) are found in a range of products from salad dressings to baked goods. Recent animal studies have demonstrated that the consumption of emulsifiers can promote intestinal inflammation by disturbing the gut microbiome. In particular, these emulsifiers have been shown to increase the abundance of pro-inflammatory bacteria and decrease beneficial microbial populations [2]. This shift in microbiota composition, known as dysbiosis, can enhance intestinal permeability, often referred to as "leaky gut," which is thought to allow harmful bacteria and toxins to translocate into the bloodstream, triggering immune responses that contribute to mucosal inflammation and tissue damage. Several studies have illustrated the direct effects of emulsifiers on intestinal cells and immune responses. For instance, exposure to emulsifiers like CMC and P80 has been shown to stimulate the release of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in both in vitro and in vivo models. These cytokines promote the activation of immune cells and the perpetuation of inflammatory pathways that characterize IBD. Furthermore, emulsifiers can exacerbate the Th17 immune response, a key driver of inflammation in IBD. This immune dysregulation is thought to heighten the severity of the disease and may also contribute to the development of extra-intestinal manifestations of IBD, such as arthritis and skin conditions [3].

Additionally, food additives and emulsifiers are implicated in altering the mucosal barrier function. The integrity of the intestinal epithelium is crucial in maintaining gut homeostasis and preventing the passage of harmful substances. Emulsifiers have been shown to disrupt tight junction proteins, which are responsible for sealing the gaps between epithelial cells. This leads to a compromised mucosal barrier, further facilitating the entry of bacteria and their products into the deeper layers of the gut lining, where they can provoke an immune response [4]. As a result, the combination of microbiome dysbiosis, increased intestinal permeability, and heightened immune activation may create a perfect storm for the initiation and exacerbation of IBD. Despite the growing body of evidence suggesting that food additives and emulsifiers play a role in IBD inflammation, much of the research is still in its early stages, particularly in human studies. While animal models provide valuable insights, they do not always translate directly to human disease, and the long-term effects of emulsifier consumption in IBD patients remain unclear. Additionally, the variability in individual responses to food additives, influenced by genetic factors, gut microbiota composition, and the presence of other environmental triggers, complicates the ability to draw definitive conclusions. Furthermore, many of the studies conducted have focused on isolated emulsifiers rather than real-world dietary patterns, which include a variety of additives and other pro-inflammatory foods [5].

Conclusion

In conclusion, while the role of food additives and emulsifiers in the pathogenesis of IBD is still an emerging area of research, current evidence strongly suggests that these substances may contribute to the initiation and exacerbation of mucosal inflammation in susceptible individuals. Dysbiosis, increased intestinal permeability, and immune activation are central mechanisms through which food additives, particularly emulsifiers, could influence IBD. As our understanding of these mechanisms improves, dietary interventions targeting the reduction of food additives may become an important adjunctive therapy in managing IBD. However, more rigorous clinical trials and longitudinal studies are needed to establish causality, understand the long-term effects, and develop evidence-based dietary guidelines for IBD patients.

Acknowledgment

None.

Conflict of Interest

None.

References

  1. Schnabel, Laure, Camille Buscail, Jean-Marc Sabate and Michel Bouchoucha, et al. "Association between ultra-processed food consumption and functional gastrointestinal disorders: Results from the French NutriNet-Santé cohort." Am J Gastroenterol 113 (2018): 1217-1228.

Google Scholar Cross Ref Indexed at

  1. Zallot, Camille, Didier Quilliot, Jean-Baptiste Chevaux and Carina Peyrin-Biroulet, et al. "Dietary beliefs and behavior among inflammatory bowel disease patients." Inflamm Bowel Dis 19 (2013): 66-72.

Google Scholar Cross Ref Indexed at

  1. Limdi, Jimmy K., Divya Aggarwal and John T. McLaughlin. "Dietary practices and beliefs in patients with inflammatory bowel disease." Inflamm Bowel Dis 22 (2016): 164-170.

Google Scholar Cross Ref Indexed at

  1. Monteleone, Ivan, Irene Marafini, Vincenzo Dinallo and Davide Di Fusco, et al. "Sodium chloride–enriched diet enhanced inflammatory cytokine production and exacerbated experimental colitis in mice." J Crohn’s Colitis 11 (2017): 237-245.

Google Scholar Cross Ref Indexed at

  1. Aguiar, Sarah Leão Fiorini, Mariana Camila Gonçalves Miranda, Mauro Andrade Freitas Guimarães and Helton Costa Santiago, et al. "High-salt diet induces IL-17-dependent gut inflammation and exacerbates colitis in mice." Immunol 8 (2018): 1969.

Google Scholar Cross Ref Indexed at

Google Scholar citation report
Citations: 77

Journal of Inflammatory Bowel Diseases & Disorders received 77 citations as per Google Scholar report

Journal of Inflammatory Bowel Diseases & Disorders peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward